Carclo plc, a precision engineering group serving the Life Sciences, Aerospace, and Safety & Security markets, has reported strong margin performance year to date, with underlying operating profit and return on sales in line with management expectations. The company provided a trading update ahead of its Annual General Meeting, held on September 9, 2026.
Year-to-date revenue was slightly behind the prior year period, reflecting the timing of Design and Engineering tooling programs and a slow first quarter for Manufacturing Solutions volumes in the CTP US business. Despite this, the company's margins, operating profit, and return on sales are ahead of last year. The Speciality division showed continued strength driven by demand from the Aerospace market, while EMEA operations saw top-line growth against the prior year. However, US operations faced slower volumes in the first quarter due to customer inventory management and project releases. In Life Sciences, certain diagnostics customers showed softer demand due to inventory levels, but demand remains strong in both civil and defense applications in Aerospace.
Net debt at the end of July was higher than the fiscal 2026 year-end due to lease extensions on US properties and working capital timing. The working capital outflow is expected to reverse by the end of the second quarter. The company attributes the margin improvement to product mix, pricing strategy, automation, and cost management actions.
Carclo's Chief Executive Officer, Frank Doorenbosch, stated: "Margins, operating profit and return on sales are all ahead of last year on slightly lower revenue, with Speciality growing strongly on Aerospace demand."
The company expects trading to be weighted toward the second half as demand strengthens. Board expectations for the full year remain unchanged and in line with targets under the Precision 2030 growth plan. Interim results for the six months ending September 30, 2026, are planned to be announced in November 2026.
